Second-line Therapy Versus Supportive Care for Pretreated Advanced Gastric Cancer
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
Because well-designed, randomized, controlled clinical trials are lacking in patients with
advanced gastric cancer (AGC), and because randomly allocating patients to treatments that do
not accord with their preferences may influence trial validity, the investigators employed a
patient preference randomized trial design to compare the efficacy of second-line
chemotherapy and best supportive care.